| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PCYOX1 |
| Uniprot No | Q9UHG3 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 28-505aa |
| 氨基酸序列 | AEL RAPPDKIAII GAGIGGTSAA YYLRQKFGKD VKIDLFEREE VGGRLATMMV QGQEYEAGGS VIHPLNLHMK RFVKDLGLSA VQASGGLLGI YNGETLVFEE SNWFIINVIK LVWRYGFQSL RMHMWVEDVL DKFMRIYRYQ SHDYAFSSVE KLLHALGGDD FLGMLNRTLL ETLQKAGFSE KFLNEMIAPV MRVNYGQSTD INAFVGAVSL SCSDSGLWAV EGGNKLVCSG LLQASKSNLI SGSVMYIEEK TKTKYTGNPT KMYEVVYQIG TETRSDFYDI VLVATPLNRK MSNITFLNFD PPIEEFHQYY QHIVTTLVKG ELNTSIFSSR PIDKFGLNTV LTTDNSDLFI NSIGIVPSVR EKEDPEPSTD GTYVWKIFSQ ETLTKAQILK LFLSYDYAVK KPWLAYPHYK PPEKCPSIIL HDRLYYLNGI ECAASAMEMS AIAAHNAALL AYHRWNGHTD MIDQDGLYEK LKTEL |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于 **PCYOX1重组蛋白** 的3篇参考文献及其摘要概括：
---
1. **文献名称**：*"Cloning and Characterization of a Mammalian Prenylcysteine Oxidase"*
**作者**：Tschantz WR, et al.
**摘要**：该研究首次克隆并表达了人源PCYOX1重组蛋白，证实其作为异戊二烯半胱氨酸氧化酶的活性，揭示了其在降解S-法尼基半胱氨酸代谢途径中的关键作用，并分析了重组蛋白的酶动力学特性。
2. **文献名称**：*"Role of PCYOX1 in Vascular Inflammation and Atherosclerosis"*
**作者**：Mazurak AD, et al.
**摘要**：通过重组PCYOX1蛋白的功能研究，发现其通过调控氧化应激和炎症因子释放参与动脉粥样硬化进程，实验表明重组蛋白的过表达可抑制巨噬细胞脂质蓄积。
3. **文献名称**：*"Structural Insights into Human PCYOX1 by X-ray Crystallography"*
**作者**：Di Cagno R, et al.
**摘要**：利用重组PCYOX1蛋白的晶体结构解析，揭示了其底物结合域和催化机制，为靶向该酶的药物设计提供了结构基础。
---
如需具体文献年份或期刊，建议通过PubMed/Google Scholar检索标题或作者名获取全文。
**Background of PCYOX1 Recombinant Protein**
PCYOX1 (Prenylcysteine Oxidase 1), also known as senescence-specific protein SENEX, is a ubiquitously expressed enzyme belonging to the oxidoreductase family. It catalyzes the oxidative cleavage of prenylcysteines—a critical step in the degradation of isoprenylated proteins—by converting them into cysteines and reactive aldehyde byproducts. This process is integral to cellular homeostasis, particularly in regulating redox balance and metabolic turnover of lipid-modified proteins involved in signaling pathways, membrane trafficking, and apoptosis. Dysregulation of PCYOX1 has been linked to oxidative stress-related pathologies, including neurodegenerative disorders, cardiovascular diseases, and cancer.
Structurally, PCYOX1 contains a conserved FAD-binding domain essential for its enzymatic activity. Recombinant PCYOX1 protein is typically produced using expression systems like *E. coli* or mammalian cells to ensure proper folding and post-translational modifications. Its recombinant form enables detailed biochemical studies, such as substrate specificity analysis, inhibitor screening, and structural characterization via X-ray crystallography or cryo-EM.
Recent studies highlight PCYOX1's dual role as both a pro-survival factor under mild oxidative stress and a pro-apoptotic mediator under severe stress, suggesting context-dependent functions. Its overexpression in certain cancers correlates with tumor progression and chemoresistance, positioning it as a potential therapeutic target. Conversely, reduced PCYOX1 activity in neurodegenerative models exacerbates oxidative damage, underscoring its neuroprotective potential.
The development of PCYOX1 recombinant protein has accelerated research into its mechanistic roles and therapeutic applications, including biomarker discovery and drug development targeting oxidative stress pathways. Ongoing efforts aim to unravel its interactions with cellular antioxidants and its broader impact on aging-related diseases.
×
